norvasc for raynaud’s
<img class="aligncenter" src="https://scx1.b-cdn.net/csz/news/800a/2023/high-fat-diet-turns-up-1.jpg"
alt="High-fat diet 'turns up the thermostat' on atherosclerosis"
title="Enpp2 gene expression and autotaxin protein levels in jejunum. A. Enpp2 gene expression after feeding a chow diet (Chow) or Western diet (WD) for two weeks. Female Enpp2fl/fl/Ldlr-/- (Cont.) mice 3.1 ± 0.4 months of age (n = 5 mice per group) and female Enpp2fl/fl/Ldlr-/-/VilCre (iKO) mice 3.9 ± 0.4 months of age (n = 5 mice per group) were fed either Chow or WD. After two weeks, enterocytes were isolated from the jejunum, clopidogrel histoire and Enpp2 gene expression was determined by RT-qPCR as described in Methods. B. Enpp2 gene expression after feeding Chow or WD for five months. Female Cont. mice, 2.6 ± 0.1 months of age (n = 5 mice per group), and female iKO mice 2.8 ± 0.1 months of age (n = 5 mice per group) were fed either Chow or WD. After five months, enterocytes were isolated from the jejunum, and Enpp2 gene expression was determined by RT-qPCR as described in Methods. C. Enterocyte autotaxin protein increased on WD in Cont. mice but not in iKO mice. Female Cont. mice or female iKO mice 4 to 5 months of age (n = 8 per group) were fed Chow or WD. After two weeks, enterocytes were prepared and highly purified by flow cytometry, the levels of autotaxin protein in the enterocytes were determined by Western blot analysis and normalized to vinculin as described in Methods. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Credit: Journal of Lipid Research (2023). DOI: 10.1016/j.jlr.2023.100370″ width=”565″ height=”291″>
In a recent study, researchers determined that derivatives of natural emulsifiers such as phospholipids found in high-fat, high-cholesterol diets can promote atherosclerosis via gut bacteria interactions with the immune system. This study could pave the way for targeted interventions for individuals who are at risk for developing heart disease.
Obesity and a high-cholesterol, high-fat diet are both well-established risk factors for atherosclerosis. In fact, obese individuals are two and a half times more likely to develop heart disease. However, the mechanistic link between obesity and atherosclerosis eludes scientists. The researchers behind this new study believe the link may be in how specific derivatives of natural emulsifiers in a Western diet alter the way that cells that line the intestines interact with gut-resident bacteria. The team published their results in the Journal of Lipid Research.
“The gut is the dietary window to the body,” said Srinivasa Reddy, professor of medicine at the University of California Los Angeles and corresponding author on the study.
Atherosclerosis, sometimes called “hardening of the arteries,” is caused by plaque buildup in blood vessels and can interfere with blood flow to critical organs, which can result in heart attack or stroke. These plaques consist of cholesterol, phospholipids and other fats; immune cells; and fibrous components.
“We study natural emulsifiers in the diet called phospholipids,” Alan Fogelman, a professor of medicine at UCLA and project supervisor, said. “For example, if you look at salad dressing and shake it up, it is the phospholipids, or emulsifiers, that keeps the oil in globules. Those emulsifiers can get modified by specific enzymes in the intestinal cells into very potent pro-inflammatory molecules in the body.”
To study the intricate connection between diet and atherosclerosis, the researchers used a mouse model that not only recapitulates the high levels of low-density lipoprotein, or “bad cholesterol,” seen in atherosclerosis patients but also lack the specific enzyme involved in the generation of pro-inflammatory derivatives of natural emulsifiers in the intestinal lining cells.
Using this model, the researchers found that on a high-fat high-cholesterol diet, the cells that line the small intestine churn out reactive phospholipids that makes the intestinal lining more susceptible to invasion by the bacteria that live in the gut.
“The normal defenses for intestinal lining cells to keep bacteria in the lumen of the intestine are reduced when they take up large amounts of cholesterol and fat,” Fogelman said.
“This also results in bacteria being able to come in direct contact with the cells lining your intestines called enterocytes. Without those defenses, this results in more bacterial products, like bacterial cell membranes that contain a toxin called endotoxin, getting into the bloodstream to cause inflammation.”
Release of bacterial products from the gut into the blood stream sounds an alarm in the immune system, which deploys immune cells into the blood to eliminate the potential threat.
“People who are obese and people eating high-fat, high-cholesterol diets have higher levels of endotoxin in their blood,” Fogelman said. “It’s not at the level of causing sepsis, but it causes a low level of inflammation. When the cholesterol and fat come into the mix, the endotoxin kind of turns up the thermostat on inflammation and that accelerates atherosclerosis and leads to increased heart attacks and strokes.”
The team is looking for ways to reduce the phospholipid derivatives that cause endotoxin to enter the blood stream. One method they have explored previously is using a mimetic of high-density lipoprotein, sometimes called “good cholesterol.”
“We created transgenic tomatoes in our lab that mimic the good cholesterol, high-density lipoprotein,” Arnab Chattopadhyay, project scientist at UCLA and lead author of the study, said. “These tomatoes, when added to a high-fat, high-cholesterol diet, help lower cholesterol and triglycerides and also lower the inflammatory derivatives of the phospholipids.”
The team said that this method of lowering cholesterol levels and triglycerides could be beneficial to obese individuals at risk for inflammatory diseases such as atherosclerosis, arthritis, lupus, multiple sclerosis and more.
More information:
Arnab Chattopadhyay et al, Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis, Journal of Lipid Research (2023). DOI: 10.1016/j.jlr.2023.100370
Journal information:
Journal of Lipid Research
Source: Read Full Article